PharmaCyte – pharmaceutical daily

April 27, 2020 Off

PharmaCyte Biotech Successfully Completes Pyrogenicity Testing

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes…

October 14, 2019 Off

PharmaCyte Biotech manufactures product to be used in clinical trial in locally advanced, inoperable pancreatic cancer

By BusinessWire

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes…

May 20, 2019 Off

PharmaCyte Biotech Proceeding with GMP Production of Pancreatic Cancer Product After Successful Changes to Manufacturing Process

By BusinessWire

PharmaCyte Biotech Proceeding with GMP Production of Pancreatic Cancer Product After Successful Changes to Manufacturing Process